Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.870
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
2.850
-0.020 (-0.70%)
After-hours: Jun 27, 2025, 4:56 PM EDT
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 8 employees as of March 31, 2025. The number of employees decreased by 2 or -20.00% compared to the previous year.
Employees
8
Change (1Y)
-2
Growth (1Y)
-20.00%
Revenue / Employee
$1,786,000
Profits / Employee
-$432,125
Market Cap
4.64M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SNOA News
- 10 days ago - Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain - Accesswire
- 3 months ago - Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) - Accesswire
- 4 months ago - Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando - Accesswire
- 5 months ago - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results - Accesswire
- 7 months ago - Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices - Accesswire
- 7 months ago - Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - Accesswire
- 8 months ago - Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - Accesswire